In addition, miR-103 hyperexpression is known to inhibit the phosphatidylinositol-3 kinase/rapamycin target signaling pathway in mammals (PI3K)/AKT/mTOR), which leads to appetite suppression and a reduced risk of obesity due to hyperphagia [57]. This evidence concerns the gene AKT1 and obesity disorder.